Skip to main content

Fertility Preservation

  • Chapter
  • First Online:
Clinical Reproductive Medicine and Surgery

Abstract

The use of fertility preservation strategies prior to chemo/radiotherapy treatments represents the only alternative to protect the chances for future reproduction in pre and post-pubertal girls. There are three available options: (a) embryo cryopreservation; (b) oocyte cryopreservation and (c) ovarian cortex cryopreservation. The first is the most established of the techniques, but it requires either a male partner or the use of donor sperm; oocyte freezing is no longer experimental and is gaining in popularity by avoiding the ethical concerns with embryo storage. Ovarian cortex freezing is still considered experimental and is considered for pre-pubertal girls and for women who cannot post-pone radio/chemotherapy. This chapter focuses on evaluating these options both for medical and social reasons. Specific indications for embryo, oocyte, and ovarian tissue cryopreservation are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Fertility preservation :

Branch of reproductive medicine aiming at preserving future fertility for patients stricken by cancer or other medical conditions requiring chemo/radiotherapy. Lately used also for preserving fertility for elective reasons

Chemotherapy :

Combination of drugs used for treating cancer or other medical conditions

Oocyte freezing :

Method to save oocytes at −196 °C

Embryo freezing :

Method to save embryos at −196 °C

Ovarian tissue freezing :

Method to save ovarian tissue at −196 º C

Controlled ovarian stimulation :

The use of fertility drugs to stimulate ovaries to produce multiple follicles

References

  1. Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044–51.

    Article  PubMed  Google Scholar 

  2. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291–301.

    Article  PubMed  Google Scholar 

  3. Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22:1837–40.

    Article  CAS  PubMed  Google Scholar 

  4. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103–7.

    Article  CAS  PubMed  Google Scholar 

  5. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG. 2005;112:1384–90.

    Article  CAS  PubMed  Google Scholar 

  6. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Yemini Z, Dor J. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril. 2007;87:418.e7–e15.

    Article  Google Scholar 

  7. Sanchez-Serrano M, Crespo J, Mirabet V, Cobo AC, Escriba MJ, Simon C, Pellicer A. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril. 2010;93:268.e11–3.

    Article  Google Scholar 

  8. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–4.

    Article  CAS  PubMed  Google Scholar 

  9. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991;55:784–91.

    Article  CAS  PubMed  Google Scholar 

  10. Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP. Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril. 1992;58:674–9.

    Article  CAS  PubMed  Google Scholar 

  11. Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA. Elevated levels of basal estradiol-17beta predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril. 1998;69:1010–4.

    Article  CAS  PubMed  Google Scholar 

  12. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718.

    Article  CAS  PubMed  Google Scholar 

  13. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:2022–6.

    Article  CAS  PubMed  Google Scholar 

  14. Statistics, SEaERC. ► http://seer.cancer.gov Accessed 20 Jul 2016.

  15. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53:727–39.

    Article  PubMed  Google Scholar 

  16. Fan W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol. 1999;57:1215–21.

    Article  CAS  PubMed  Google Scholar 

  17. McLaughlin M, Kinnell HL, Anderson RA, Telfer EE. Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles. Mol Hum Reprod. 2014;20:736–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Roness H, Kashi O, Meirow D. Prevention of chemotherapy-induced ovarian damage. Fertil Steril. 2016;105:20–9.

    Article  CAS  PubMed  Google Scholar 

  19. Livera G, Petre-Lazar B, Guerquin MJ, Trautmann E, Coffigny H, Habert R. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction. 2008;135:3–12.

    Article  CAS  PubMed  Google Scholar 

  20. Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011;3:782–93.

    Article  Google Scholar 

  21. You W, Dainty LA, Rose GS, Krivak T, McHale MT, Olsen CH, Elkas JC. Gynecologic malignancies in women aged less than 25 years. Obstet Gynecol. 2005;105:1405–9.

    Article  PubMed  Google Scholar 

  22. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med. 1981;71:552–6.

    Article  CAS  PubMed  Google Scholar 

  23. Multidisciplinary Working Group convened by the British Fertility Society. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb). 2003;6:A1–40.

    Article  Google Scholar 

  24. Bath LE, Tydeman G, Critchley HO, Anderson RA, Baird DT, Wallace WH. Spontaneous conception in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis: case report. Hum Reprod. 2004;19:2569–72.

    Article  CAS  PubMed  Google Scholar 

  25. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18:2368–74.

    Article  CAS  PubMed  Google Scholar 

  26. Crofton PM, Thomson AB, Evans AE, Groome NP, Bath LE, Kelnar CJ, Wallace WH. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer? Clin Endocrinol (Oxf). 2003;58:296–301.

    Article  CAS  Google Scholar 

  27. Gaetini A, De Simone M, Urgesi A, Levis A, Resegotti A, Ragona R, Anglesio S. Lateral high abdominal ovariopexy: an original surgical technique for protection of the ovaries during curative radiotherapy for Hodgkin's disease. J Surg Oncol. 1988;39:22–8.

    Article  CAS  PubMed  Google Scholar 

  28. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50.

    Article  CAS  PubMed  Google Scholar 

  29. Lushbaugh CC, Casarett GW. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer. 1976;37:1111–25.

    Article  CAS  PubMed  Google Scholar 

  30. Meirow D, Schenker JG, Rosler A. Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 alpha-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens? Hum Reprod. 1996;11:2119–21.

    Article  CAS  PubMed  Google Scholar 

  31. Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74:743–8.

    Article  CAS  PubMed  Google Scholar 

  32. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–44.

    Article  PubMed  Google Scholar 

  33. Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer. 1999;86:2138–42.

    Article  CAS  PubMed  Google Scholar 

  34. Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit Rev Oncol Hematol. 2010;74:175–92.

    Article  PubMed  Google Scholar 

  35. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr. 2005;2005(34):64–8.

    Article  Google Scholar 

  36. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109:107–14.

    Article  PubMed  Google Scholar 

  37. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989;43:399–402.

    Article  CAS  PubMed  Google Scholar 

  38. Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120:326–33.

    Article  PubMed  Google Scholar 

  39. Plante M, Renaud MC, Francois H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol. 2004;94:614–23.

    Article  PubMed  Google Scholar 

  40. Plante M. Fertility preservation in the management of cervical cancer. CME J Gynecol Oncol. 2003;8:97–107.

    Google Scholar 

  41. Johansen G, Lonnerfors C, Falconer H, Persson J. Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol. 2016;141:160–5.

    Article  PubMed  Google Scholar 

  42. Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim Jr HA, Peccatori FA, Costa M, Revelli A, Salvagno F, Gennari A, Ubaldi FM, La Sala GB, De Stefano C, Wallace WH, Partridge AH, Anserini P. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Howard FM. Laparoscopic lateral ovarian transposition before radiation treatment of Hodgkin disease. J Am Assoc Gynecol Laparosc. 1997;4:601–4.

    Article  CAS  PubMed  Google Scholar 

  44. Treissman MJ, Miller D, McComb PF. Laparoscopic lateral ovarian transposition. Fertil Steril. 1996;65:1229–31.

    Article  CAS  PubMed  Google Scholar 

  45. Yarali H, Demirol A, Bukulmez O, Coskun F, Gurgan T. Laparoscopic high lateral transposition of both ovaries before pelvic irradiation. J Am Assoc Gynecol Laparosc. 2000;7:237–9.

    Article  CAS  PubMed  Google Scholar 

  46. Bidzinski M, Lemieszczuk B, Zielinski J. Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation. Eur J Gynaecol Oncol. 1993;14:77–80.

    PubMed  Google Scholar 

  47. Morice P, Castaigne D, Haie-Meder C, Pautier P, El Hassan J, Duvillard P, Gerbaulet A, Michel G. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril. 1998;70:956–60.

    Article  CAS  PubMed  Google Scholar 

  48. Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol. 1995;56:3–7.

    Article  CAS  PubMed  Google Scholar 

  49. Roness H, Gavish Z, Cohen Y, Meirow D. Ovarian follicle burnout: a universal phenomenon? Cell Cycle. 2013;12:3245–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18:525–35.

    Article  CAS  PubMed  Google Scholar 

  51. Hasky N, Uri-Belapolsky S, Goldberg K, Miller I, Grossman H, Stemmer SM, Ben-Aharon I, Shalgi R. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma? Hum Reprod. 2015;30:1089–101.

    Article  PubMed  Google Scholar 

  52. Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens Jr FL, Gelber RD, Hortobagyi GN, Albain KS, Investigators PS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372:923–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Lambertini M, Boni L, Michelotti A, Gamucci T, Scotto T, Gori S, Giordano M, Garrone O, Levaggi A, Poggio F, Giraudi S, Bighin C, Vecchio C, Sertoli MR, Pronzato P, Del Mastro L, GIM Study Group. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial. JAMA. 2015;314:2632–40.

    Article  CAS  PubMed  Google Scholar 

  54. Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34:2568–74.

    Article  CAS  PubMed  Google Scholar 

  55. Hickman LC, Valentine LN, Falcone T. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists. Am J Obstet Gynecol. 2016;215(4):415–22.

    Article  CAS  PubMed  Google Scholar 

  56. Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214–23.

    Article  Google Scholar 

  57. Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol. 2009;21:270–4.

    Article  PubMed  Google Scholar 

  58. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18:90–5.

    Article  CAS  PubMed  Google Scholar 

  59. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002;8:129–39.

    Article  CAS  PubMed  Google Scholar 

  60. Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23:323–33.

    Article  CAS  PubMed  Google Scholar 

  61. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92:1360–5.

    Article  Google Scholar 

  62. Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37–43.

    Article  Google Scholar 

  63. Oktay K, Kan MT, Rosenwaks Z. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol. 2001;13:263–8.

    Article  CAS  PubMed  Google Scholar 

  64. Magistrini M, Szollosi D. Effects of cold and of isopropyl-N-phenylcarbamate on the second meiotic spindle of mouse oocytes. Eur J Cell Biol. 1980;22:699–707.

    CAS  PubMed  Google Scholar 

  65. Stachecki JJ, Cohen J, Willadsen S. Detrimental effects of sodium during mouse oocyte cryopreservation. Biol Reprod. 1998;59:395–400.

    Article  CAS  PubMed  Google Scholar 

  66. Shaw JM, Jones GM. Terminology associated with vitrification and other cryopreservation procedures for oocytes and embryos. Hum Reprod Update. 2003;9:583–605.

    Article  CAS  PubMed  Google Scholar 

  67. Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105:459–66.. e2

    Article  PubMed  Google Scholar 

  68. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.

    Article  CAS  PubMed  Google Scholar 

  69. ESHRE Task Force on Ethics and Law, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K. Oocyte cryopreservation for age-related fertility loss. Hum Reprod. 2012;27:1231–7.

    Article  Google Scholar 

  70. Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohi J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755–64.. e8

    Article  PubMed  Google Scholar 

  71. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.

    Article  CAS  PubMed  Google Scholar 

  72. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630–5.

    Article  CAS  PubMed  Google Scholar 

  73. Evans AC. Characteristics of ovarian follicle development in domestic animals. Reprod Domest Anim. 2003;38:240–6.

    Article  CAS  PubMed  Google Scholar 

  74. Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril. 2003;80:116–22.

    Article  PubMed  Google Scholar 

  75. McNatty KP, Hillier SG, van den Boogaard AM, Trimbos-Kemper TC, Reichert Jr LE, van Hall EV. Follicular development during the luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 1983;56:1022–31.

    Article  CAS  PubMed  Google Scholar 

  76. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014;29:684–91.

    Article  PubMed  Google Scholar 

  77. Ubaldi FM, Capalbo A, Vaiarelli A, Cimadomo D, Colamaria S, Alviggi C, Trabucco E, Venturella R, Vajta G, Rienzi L. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016;105:1488–95.. e1

    Article  PubMed  Google Scholar 

  78. Oktay K, Buyuk E. The potential of ovarian tissue transplant to preserve fertility. Expert Opin Biol Ther. 2002;2:361–70.

    Article  PubMed  Google Scholar 

  79. Aubard Y. Ovarian tissue graft: from animal experiment to practice in the human. Eur J Obstet Gynecol Reprod Biol. 1999;86:1–3.

    Article  CAS  PubMed  Google Scholar 

  80. Baird DT, Webb R, Campbell BK, Harkness LM, Gosden RG. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at −196 ° C. Endocrinology. 1999;140:462–71.

    Article  CAS  PubMed  Google Scholar 

  81. Oktay K, Nugent D, Newton H, Salha O, Chatterjee P, Gosden RG. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril. 1997;67:481–6.

    Article  CAS  PubMed  Google Scholar 

  82. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–10.

    Article  CAS  PubMed  Google Scholar 

  83. Lomax CW, Harbert Jr GM, Thornton Jr WN. Actinomycosis of the female genital tract. Obstet Gynecol. 1976;48:341–6.

    CAS  PubMed  Google Scholar 

  84. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318–21.

    Article  CAS  PubMed  Google Scholar 

  85. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M, Rosenwaks Z. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363:837–40.

    Article  PubMed  Google Scholar 

  86. Andersen CY. Success and challenges in fertility preservation after ovarian tissue grafting. Lancet. 2015;385:1947–8.

    Article  PubMed  Google Scholar 

  87. Smitz JE, Thompson JG, Gilchrist RB. The promise of in vitro maturation in assisted reproduction and fertility preservation. Semin Reprod Med. 2011;29:24–37.

    Article  CAS  PubMed  Google Scholar 

  88. Wallin A, Ghahremani M, Dahm-Kahler P, Brannstrom M. Viability and function of the cryopreserved whole ovary: in vitro studies in the sheep. Hum Reprod. 2009;24:1684–94.

    Article  PubMed  Google Scholar 

  89. Brännström M, Milenkovic M. Whole ovary cryopreservation with vascular transplantation – a future development in female oncofertility. Middle East Fertil Soc J. 2010;15:125–38.

    Article  Google Scholar 

  90. Racho El-Akouri R, Kurlberg G, Dindelegan G, Molne J, Wallin A, Brannstrom M. Heterotopic uterine transplantation by vascular anastomosis in the mouse. J Endocrinol. 2002;174:157–66.

    Article  CAS  PubMed  Google Scholar 

  91. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med. 2008;359:2617–8.

    Article  CAS  PubMed  Google Scholar 

  92. Wranning CA, Akhi SN, Kurlberg G, Brannstrom M. Uterus transplantation in the rat: model development, surgical learning and morphological evaluation of healing. Acta Obstet Gynecol Scand. 2008;87:1239–47.

    Article  PubMed  Google Scholar 

  93. Wranning CA, El-Akouri RR, Lundmark C, Dahm-Kahler P, Molne J, Enskog A, Brannstrom M. Auto-transplantation of the uterus in the domestic pig (Sus scrofa): surgical technique and early reperfusion events. J Obstet Gynaecol Res. 2006;32:358–67.

    Article  PubMed  Google Scholar 

  94. Imhof M, Bergmeister H, Lipovac M, Rudas M, Hofstetter G, Huber J. Orthotopic microvascular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. Fertil Steril. 2006;85(Suppl 1):1208–15.

    Article  PubMed  Google Scholar 

  95. Torre A, Vertu-Ciolino D, Mazoyer C, Selva J, Lornage J, Salle B. Safeguarding fertility with whole ovary cryopreservation and microvascular transplantation: higher follicular survival with vitrification than with slow freezing in a ewe model. Transplantation. 2016;100(9):1889–97.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pasquale Patrizio MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Patrizio, P., Molinari, E., Falcone, T., Westphal, L.M. (2017). Fertility Preservation. In: Falcone, T., Hurd, W. (eds) Clinical Reproductive Medicine and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-52210-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52210-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52209-8

  • Online ISBN: 978-3-319-52210-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics